[go: up one dir, main page]

AR106385A1 - Composición cosmética que comprende bacterias probióticas - Google Patents

Composición cosmética que comprende bacterias probióticas

Info

Publication number
AR106385A1
AR106385A1 ARP160103167A ARP160103167A AR106385A1 AR 106385 A1 AR106385 A1 AR 106385A1 AR P160103167 A ARP160103167 A AR P160103167A AR P160103167 A ARP160103167 A AR P160103167A AR 106385 A1 AR106385 A1 AR 106385A1
Authority
AR
Argentina
Prior art keywords
cosmetic composition
probiotic bacteria
bifidobacteria
includes probiotic
mixture
Prior art date
Application number
ARP160103167A
Other languages
English (en)
Original Assignee
Natura Cosmeticos Sa
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natura Cosmeticos Sa, Univ Minas Gerais filed Critical Natura Cosmeticos Sa
Publication of AR106385A1 publication Critical patent/AR106385A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)

Abstract

Reivindicación 1: Una composición cosmética que comprende un ingrediente probiótico seleccionado de Bifidobacteria longum 5¹A; Bifidobacteria bifidum 162²A; Bifidobacteria breve 110¹A; Bifidobacteria pseudolongum 119¹A, o una mezcla de las mismas y excipientes cosméticamente aceptables.
ARP160103167A 2015-10-15 2016-10-17 Composición cosmética que comprende bacterias probióticas AR106385A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562242017P 2015-10-15 2015-10-15

Publications (1)

Publication Number Publication Date
AR106385A1 true AR106385A1 (es) 2018-01-10

Family

ID=58516882

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160103167A AR106385A1 (es) 2015-10-15 2016-10-17 Composición cosmética que comprende bacterias probióticas

Country Status (9)

Country Link
US (1) US20180311144A1 (es)
EP (1) EP3362038A4 (es)
AR (1) AR106385A1 (es)
AU (1) AU2016338321A1 (es)
BR (1) BR112018007560A2 (es)
CA (1) CA3001920A1 (es)
CL (1) CL2018000963A1 (es)
MX (1) MX2018004616A (es)
WO (1) WO2017063066A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3212001A4 (en) 2014-10-31 2018-04-25 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
US11103443B2 (en) 2017-05-22 2021-08-31 Dermala Compositions and methods for preventing, slowing, and reversing skin aging
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
FR3075622B1 (fr) * 2017-12-22 2020-01-17 L V M H Recherche Composition cosmetique comprenant un extrait de caesalpinia spinosa, un extrait de kappaphycus alvarezii, au moins un prebiotique et un probiotique.
FR3075647B1 (fr) * 2017-12-22 2020-05-22 L V M H Recherche Composition de maquillage comprenant un hydrolysat de feves de theobroma cacao l, et au moins un prebiotique et un probiotique
AU2019306649A1 (en) 2018-07-19 2021-02-04 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
CN114341991A (zh) 2019-09-02 2022-04-12 联合利华知识产权控股有限公司 使用网络分析作为用于治疗人类皮肤生态失调的工具
WO2021163736A1 (en) * 2020-02-10 2021-08-19 HANG, Nguyen Tuy Probiotic-containing natural composition for cleaning the body, which is capable of deodorizing, decomposing organic matters adhered to the body and the body cleaning products made from this composition
KR102283637B1 (ko) * 2020-03-24 2021-07-30 주식회사 아이코맥스 과피 발효물을 포함하는 고기능성 화장료 조성물
JPWO2022064839A1 (es) * 2020-09-24 2022-03-31
WO2024062470A1 (en) 2022-09-21 2024-03-28 Moraz Medical Herbs (1989) Ltd. Dermal and cosmetic compositions
CN116590201B (zh) * 2023-07-10 2023-12-12 中国农业大学 一种抑制皮肤胶原纤维化的长双歧杆菌及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
WO2006037922A1 (fr) * 2004-10-04 2006-04-13 L'oreal Composition cosmetique et/ou dermatologique pour peaux sensibles
ES2640212T3 (es) * 2005-04-08 2017-11-02 The Procter & Gamble Company Uso de bifidobacterias pro bióticas administradas por vía oral para obtener beneficios de belleza en seres humanos
FR2920305B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920306B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation cosmetique d'un lysat de bifidobacterieum species.
FR2920304B1 (fr) * 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
ES2331863B1 (es) * 2008-07-15 2010-10-27 Consejo Superior De Investigaciones Cientificas (Csic) Bacterias y productos derivados para fortalecer las defensas y reducir el riesgo de enfermedad.
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
FR2937548B1 (fr) * 2008-10-28 2010-12-31 Oreal Utilisation d'un lysat de bifidobacterium species pour preparer la peau d'un sujet a traitement cutane de surface
FR2937547B1 (fr) * 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
US20130004463A1 (en) * 2010-01-06 2013-01-03 Kabushiki Kaisha Yakult Honsha Dna damage repair promoter for oral application, and elastase activity inhibitor for oral application
FR2959128B1 (fr) * 2010-04-23 2012-07-13 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
DE102011009798B4 (de) * 2011-01-31 2015-03-05 Merz Pharma Gmbh & Co. Kgaa Balneologische lipidhaltige probiotische Zubereitungen für kosmetische / dermatologische / medizinische Anwendungen
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
JP6234465B2 (ja) * 2013-08-29 2017-11-22 株式会社ヤクルト本社 コラーゲン線維の結束能増強剤
KR102111752B1 (ko) * 2013-11-15 2020-05-15 주식회사 엘지생활건강 콜라겐 합성 촉진용 조성물
EP3102670A4 (en) * 2014-02-04 2017-07-12 Micro-nature LLC Systems, methods, and compositions relating to combiomics

Also Published As

Publication number Publication date
CA3001920A1 (en) 2017-04-20
CL2018000963A1 (es) 2018-12-07
MX2018004616A (es) 2019-06-20
BR112018007560A2 (pt) 2018-10-23
AU2016338321A1 (en) 2018-05-17
US20180311144A1 (en) 2018-11-01
EP3362038A4 (en) 2019-05-15
EP3362038A1 (en) 2018-08-22
WO2017063066A1 (en) 2017-04-20

Similar Documents

Publication Publication Date Title
AR106385A1 (es) Composición cosmética que comprende bacterias probióticas
MX2020001555A (es) Preparaciones terapéuticas de glicanos y métodos relacionados con estas.
MX2019009839A (es) Celulas eritroides funcionalizadas.
MX2022010168A (es) Moduladores de calpainas y usos terapeuticos de los mismos.
EP3536168A3 (en) Probiotic formulations and methods for use
MX390014B (es) Compuestos de dinucleótidos cíclicos y métodos de uso.
CA2956871C (en) Compounds active towards bromodomains
MX2020005446A (es) Metodos para marcar una molecula deuterada o no deuterada y formulaciones farmaceuticas para tratamiento.
MX2017000254A (es) Sistema para la administracion de una composicion de higiene bucal.
MX2020011478A (es) Formas solidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il) -1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmaceuticas y usos.
MX2017015674A (es) Suplemento dietetico.
MX2019014772A (es) Formulaciones en gel de bisfosfocinas y usos de estas.
MX387731B (es) Composiciones farmacéuticas orales de mesalazina.
UY36761A (es) Formulación oral sólida que contiene irinotecán y método 20 de preparación de la misma
AU201712741S (en) Oral Care Implement
PH12020550217A1 (en) Nutrient-spore formulations and uses thereof
AU201712739S (en) Oral Care Implement
WO2017123610A3 (en) Bacteria engineered to detoxify deleterious molecules
MX2018009364A (es) Sal de succinato de citisina y uso de la misma.
AR108233A1 (es) Composiciones farmacéuticas orales de nicotinamida
PH12018502139A1 (en) Phosphaplatin liquid formulations
PH12018501758A1 (en) Oritavancin formulations
MX391400B (es) Formulaciones farmacéuticas de matriz que comprenden dimetilfumarato.
MX2019015869A (es) Nuevas formulaciones orales de belinostat.
WO2016033549A3 (en) (17-β)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE

Legal Events

Date Code Title Description
FB Suspension of granting procedure